Business Description
Karo Pharma AB
NAICS : 325412
ISIN : SE0007464888
Description
Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | 1.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -12.51 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Karo Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 2,961.453 | ||
| EPS (TTM) (kr) | -0.089 | ||
| Beta | 0 | ||
| Volatility % | 1.34 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (kr) | 0 | ||
| 20-Day SMA (kr) | 61.2 | ||
| 12-1 Month Momentum % | 1.32 | ||
| 52-Week Range (kr) | 60.39245 - 61.2 | ||
| Shares Outstanding (Mil) | 273.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Karo Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Karo Pharma AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Karo Pharma AB Frequently Asked Questions
What is Karo Pharma AB(LTS:0RAQ)'s stock price today?
The current price of LTS:0RAQ is kr61.20. The 52 week high of LTS:0RAQ is kr61.20 and 52 week low is kr60.39.
When is next earnings date of Karo Pharma AB(LTS:0RAQ)?
The next earnings date of Karo Pharma AB(LTS:0RAQ) is 2024-07-21 Est..
Does Karo Pharma AB(LTS:0RAQ) pay dividends? If so, how much?
Karo Pharma AB(LTS:0RAQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers